Brief: PhytoHealth Corporation Announced A New Clinical Study Results Published At 2024 Esmo Congress Pg2 Plus Preoperative Chemoradiotherapy Improves Survival In Patients With Locally Advanced Esophageal Cancer
16/09/2024 12:35
Sept 16 (Reuters) - Phytohealth Corp 4108.TW :
* PHYTOHEALTH CORPORATION ANNOUNCED A NEW CLINICAL STUDY
RESULTS
PUBLISHED AT 2024 ESMO CONGRESS: PG2 PLUS PREOPERATIVE
CHEMORADIOTHERAPY IMPROVES SURVIVAL IN PATIENTS WITH LOCALLY
ADVANCED ESOPHAGEAL CANCER
Source text for Eikon: ID:nPrex6fj5a
Further company coverage: 4108.TW
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Phytohealth
See all newsBrief: PhytoHealth Corporation Announced A New Clinical Study Results Published At 2024 Esmo Congress Pg2 Plus Preoperative Chemoradiotherapy Improves Survival In Patients With Locally Advanced Esophageal Cancer
Brief: Phytohealth Posts Losses Of T$7.4 Mln In Q1
Brief: PhytoHealth says no dividend payment for 2017
Brief: Phytohealth says no dividend for 2016
Brief: PhytoHealth says change of corporate auditor